BIOMAT Database Logo BIOMAT Database Logo

Design of potent and specific inhibitors of carboxypeptidases A and B. 1979

M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman

The combination in one molecule of functional groups that can interact specifically with different substrate binding areas at the active site of carboxypeptidases A and B has led to the development of potent and specific inhibitors of these enzymes. 2-Benzyl-3-mercaptopropanoic acid (SQ 14,603) has a Ki of 1.1 x 10(-8) M vs. carboxypeptidase A and a Ki of 1.6 x 10(-4) M vs. the B enzyme. 2-Mercaptomethyl-5-guanidinopentanoic acid (SQ 24,798) has a Ki of 4 x 10(-10) M vs. carboxypeptidase B and a Ki of 1.2 x 10(-5) M vs. carboxypeptidase A. It is proposed that the sulfhydryl groups of these inhibitors bind to the catalytically important zinc ions of these enzymes, and that, in conjunction with the benzyl and guanidinopropyl side chains, they are responsible for their specificity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002268 Carboxypeptidases Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue. Carboxypeptidase
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013438 Sulfhydryl Compounds Compounds containing the -SH radical. Mercaptan,Mercapto Compounds,Sulfhydryl Compound,Thiol,Thiols,Mercaptans,Compound, Sulfhydryl,Compounds, Mercapto,Compounds, Sulfhydryl
D015097 3-Mercaptopropionic Acid An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions. 3-Mercaptopropanoic Acid,beta-Mercaptopropionate,3 Mercaptopropanoic Acid,3 Mercaptopropionic Acid,Acid, 3-Mercaptopropanoic,Acid, 3-Mercaptopropionic,beta Mercaptopropionate

Related Publications

M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Design and use of potent, specific enzyme inhibitors.
January 1983, Pharmacology & therapeutics,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Carboxypeptidases A and B.
January 1977, Methods in enzymology,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Design and Synthesis of Highly Potent and Specific ABHD6 Inhibitors.
November 2023, ChemMedChem,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
February 2011, Bioorganic & medicinal chemistry letters,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
[21] carboxypeptidases a and B.
January 1972, Methods in enzymology,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Design of new antihypertensive drugs: potent and specific inhibitors of angiotensin-converting enzyme.
January 1978, Progress in cardiovascular diseases,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
May 2016, European journal of medicinal chemistry,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Design of potent B-RafV600E inhibitors by multiple copy simulation search strategy.
February 2018, Chemical biology & drug design,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Removal of specific C-terminal residues from human hemoglobin using carboxypeptidases A and B.
January 1981, Methods in enzymology,
M A Ondetti, and M E Condon, and J Reid, and E F Sabo, and H S Cheung, and D W Cushman
Design and synthesis of potent RSK inhibitors.
October 2018, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!